DELCATH SYSTEMS INC (DCTH) Fundamental Analysis & Valuation

NASDAQ:DCTHUS24661P8077

Current stock price

10.05 USD
+0.17 (+1.72%)
Last:

This DCTH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. DCTH Profitability Analysis

1.1 Basic Checks

  • DCTH had positive earnings in the past year.
  • DCTH had a positive operating cash flow in the past year.
  • DCTH had negative earnings in 4 of the past 5 years.
  • In the past 5 years DCTH reported 4 times negative operating cash flow.
DCTH Yearly Net Income VS EBIT VS OCF VS FCFDCTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.18%, DCTH is in the better half of the industry, outperforming 73.94% of the companies in the same industry.
  • DCTH's Return On Equity of 2.43% is fine compared to the rest of the industry. DCTH outperforms 73.94% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 0.45%, DCTH is in the better half of the industry, outperforming 65.96% of the companies in the same industry.
Industry RankSector Rank
ROA 2.18%
ROE 2.43%
ROIC 0.45%
ROA(3y)-51.91%
ROA(5y)-87.52%
ROE(3y)-112.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DCTH Yearly ROA, ROE, ROICDCTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

1.3 Margins

  • DCTH has a better Profit Margin (3.17%) than 73.94% of its industry peers.
  • With a decent Operating Margin value of 0.77%, DCTH is doing good in the industry, outperforming 65.96% of the companies in the same industry.
  • DCTH has a Gross Margin of 86.16%. This is amongst the best in the industry. DCTH outperforms 95.21% of its industry peers.
  • In the last couple of years the Gross Margin of DCTH has grown nicely.
Industry RankSector Rank
OM 0.77%
PM (TTM) 3.17%
GM 86.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.9%
GM growth 5Y7.08%
DCTH Yearly Profit, Operating, Gross MarginsDCTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

8

2. DCTH Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DCTH is destroying value.
  • Compared to 1 year ago, DCTH has more shares outstanding
  • The number of shares outstanding for DCTH has been increased compared to 5 years ago.
  • DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DCTH Yearly Shares OutstandingDCTH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DCTH Yearly Total Debt VS Total AssetsDCTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 12.37 indicates that DCTH is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of DCTH (12.37) is better than 92.02% of its industry peers.
  • DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.37
ROIC/WACC0.05
WACC8.93%
DCTH Yearly LT Debt VS Equity VS FCFDCTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • DCTH has a Current Ratio of 10.92. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
  • DCTH has a Current ratio of 10.92. This is amongst the best in the industry. DCTH outperforms 94.68% of its industry peers.
  • DCTH has a Quick Ratio of 9.98. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of DCTH (9.98) is better than 95.21% of its industry peers.
Industry RankSector Rank
Current Ratio 10.92
Quick Ratio 9.98
DCTH Yearly Current Assets VS Current LiabilitesDCTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

8

3. DCTH Growth Analysis

3.1 Past

  • DCTH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.14%, which is quite impressive.
  • The Revenue has grown by 129.08% in the past year. This is a very strong growth!
  • The Revenue has been growing by 120.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)107.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.55%
Revenue 1Y (TTM)129.08%
Revenue growth 3Y215.27%
Revenue growth 5Y120.1%
Sales Q2Q%37.27%

3.2 Future

  • The Earnings Per Share is expected to grow by 80.28% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 22.01% on average over the next years. This is a very strong growth
EPS Next Y-44.63%
EPS Next 2Y147.39%
EPS Next 3Y123.09%
EPS Next 5Y80.28%
Revenue Next Year22.68%
Revenue Next 2Y27.81%
Revenue Next 3Y25.62%
Revenue Next 5Y22.01%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DCTH Yearly Revenue VS EstimatesDCTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M
DCTH Yearly EPS VS EstimatesDCTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -200M -400M -600M -800M -1B

4

4. DCTH Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 143.57, the valuation of DCTH can be described as expensive.
  • DCTH's Price/Earnings ratio is a bit cheaper when compared to the industry. DCTH is cheaper than 64.89% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, DCTH is valued quite expensively.
  • The Price/Forward Earnings ratio is 259.29, which means the current valuation is very expensive for DCTH.
  • Based on the Price/Forward Earnings ratio, DCTH is valued a bit cheaper than 65.43% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of DCTH to the average of the S&P500 Index (23.68), we can say DCTH is valued expensively.
Industry RankSector Rank
PE 143.57
Fwd PE 259.29
DCTH Price Earnings VS Forward Price EarningsDCTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DCTH is valued a bit cheaper than 63.30% of the companies in the same industry.
  • 93.09% of the companies in the same industry are more expensive than DCTH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.65
EV/EBITDA 227.96
DCTH Per share dataDCTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • DCTH's earnings are expected to grow with 123.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y147.39%
EPS Next 3Y123.09%

0

5. DCTH Dividend Analysis

5.1 Amount

  • No dividends for DCTH!.
Industry RankSector Rank
Dividend Yield 0%

DCTH Fundamentals: All Metrics, Ratios and Statistics

DELCATH SYSTEMS INC

NASDAQ:DCTH (4/10/2026, 2:20:42 PM)

10.05

+0.17 (+1.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners50.2%
Inst Owner Change0%
Ins Owners2.92%
Ins Owner Change1%
Market Cap349.24M
Revenue(TTM)85.23M
Net Income(TTM)2.70M
Analysts84.62
Price Target22.59 (124.78%)
Short Float %12.21%
Short Ratio8.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.28%
Min EPS beat(2)-1.96%
Max EPS beat(2)20.51%
EPS beat(4)3
Avg EPS beat(4)72.29%
Min EPS beat(4)-1.96%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)-11.78%
EPS beat(12)6
Avg EPS beat(12)-19.4%
EPS beat(16)7
Avg EPS beat(16)-18.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-3.57%
Max Revenue beat(2)-0.02%
Revenue beat(4)2
Avg Revenue beat(4)3.85%
Min Revenue beat(4)-3.57%
Max Revenue beat(4)15.26%
Revenue beat(8)6
Avg Revenue beat(8)14.28%
Revenue beat(12)6
Avg Revenue beat(12)1.9%
Revenue beat(16)9
Avg Revenue beat(16)7.21%
PT rev (1m)-4.32%
PT rev (3m)-4.32%
EPS NQ rev (1m)-233.35%
EPS NQ rev (3m)-292.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-89.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.57%
Revenue NY rev (1m)-3.61%
Revenue NY rev (3m)-11.55%
Valuation
Industry RankSector Rank
PE 143.57
Fwd PE 259.29
P/S 4.1
P/FCF 16.65
P/OCF 15.51
P/B 3.14
P/tB 3.14
EV/EBITDA 227.96
EPS(TTM)0.07
EY0.7%
EPS(NY)0.04
Fwd EY0.39%
FCF(TTM)0.6
FCFY6%
OCF(TTM)0.65
OCFY6.45%
SpS2.45
BVpS3.2
TBVpS3.2
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.25
Profitability
Industry RankSector Rank
ROA 2.18%
ROE 2.43%
ROCE 0.59%
ROIC 0.45%
ROICexc 2.35%
ROICexgc 2.35%
OM 0.77%
PM (TTM) 3.17%
GM 86.16%
FCFM 24.6%
ROA(3y)-51.91%
ROA(5y)-87.52%
ROE(3y)-112.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.9%
GM growth 5Y7.08%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 650%
Cap/Sales 1.82%
Interest Coverage 250
Cash Conversion 2507.35%
Profit Quality 776.63%
Current Ratio 10.92
Quick Ratio 9.98
Altman-Z 12.37
F-Score7
WACC8.93%
ROIC/WACC0.05
Cap/Depr(3y)370.83%
Cap/Depr(5y)273.47%
Cap/Sales(3y)2.04%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.55%
EPS Next Y-44.63%
EPS Next 2Y147.39%
EPS Next 3Y123.09%
EPS Next 5Y80.28%
Revenue 1Y (TTM)129.08%
Revenue growth 3Y215.27%
Revenue growth 5Y120.1%
Sales Q2Q%37.27%
Revenue Next Year22.68%
Revenue Next 2Y27.81%
Revenue Next 3Y25.62%
Revenue Next 5Y22.01%
EBIT growth 1Y105.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year913.35%
EBIT Next 3Y331.54%
EBIT Next 5YN/A
FCF growth 1Y208.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y220.53%
OCF growth 3YN/A
OCF growth 5YN/A

DELCATH SYSTEMS INC / DCTH Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DELCATH SYSTEMS INC (DCTH) stock?

ChartMill assigns a fundamental rating of 6 / 10 to DCTH.


What is the valuation status of DELCATH SYSTEMS INC (DCTH) stock?

ChartMill assigns a valuation rating of 4 / 10 to DELCATH SYSTEMS INC (DCTH). This can be considered as Fairly Valued.


How profitable is DELCATH SYSTEMS INC (DCTH) stock?

DELCATH SYSTEMS INC (DCTH) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for DCTH stock?

The Price/Earnings (PE) ratio for DELCATH SYSTEMS INC (DCTH) is 143.57 and the Price/Book (PB) ratio is 3.14.


Can you provide the financial health for DCTH stock?

The financial health rating of DELCATH SYSTEMS INC (DCTH) is 8 / 10.